Aphria Inc. | Mutual Funds
Mutual Funds that own Aphria Inc.
6,030,576
2.6%
34,538
10.7%
07/31/2018
Vanguard Total International Stock Index Fund
2,586,058
1.11%
58,400
0.01%
07/31/2018
Manulife Canadian Focused Fund
1,068,138
0.46%
-1,248,006
1.74%
12/31/2017
Vanguard Developed Markets Index Fund
1,016,236
0.44%
-940
0.01%
07/31/2018
850,135
0.37%
850,135
1.93%
06/29/2018
Canadian General Investments Ltd.
675,000
0.28%
675,000
1.23%
06/30/2018
Vanguard FTSE All World (ex-US) Small Cap
450,483
0.19%
12,635
0.09%
07/31/2018
CREF Stock Account
373,184
0.16%
-75,173
0%
03/31/2018
iShares Core S&P/TSX Capped Composite Index ETF
363,490
0.16%
6,612
0.15%
09/06/2018
TD Emerald Canadian Equity Index Fund
282,900
0.12%
282,900
0.1%
12/31/2017
| Address |
269 Erie Street West
Leamington Ontario N8H 3C4
Canada
|
|
Employees
|
- |
| Website |
http://www.aphria.com |
| Updated |
09/14/2018 |
| Aphria, Inc. engages in the production and supply of medical marijuana. Its products include alien dawg, champlian indica, grower's blend, champlain-sativa and blueberry. The company was founded by Cole Cacciavillani and John Cervini on June 22, 2011 and is headquartered in Leamington, Canada. |
